Stevanato Group S.p.A. (NYSE:STVN) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Stevanato Group S.p.A. (NYSE:STVN) have been assigned an average recommendation of “Moderate Buy” from the seven analysts that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and two have assigned a strong buy recommendation to the company.

Several equities analysts have recently commented on STVN shares. UBS Group initiated coverage on Stevanato Group in a report on Wednesday. They set a “neutral” rating and a $23.00 target price for the company. TD Cowen raised Stevanato Group to a “strong-buy” rating in a report on Wednesday, June 17th. Wolfe Research assumed coverage on Stevanato Group in a research report on Tuesday, June 2nd. They set an “outperform” rating and a $21.00 price objective for the company. Finally, Weiss Ratings raised Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, August 27th.

Insider Buying and Selling at Stevanato Group

In other Stevanato Group news, Director Elisabetta Magistretti sold 2,045 shares of the firm’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of €20.09, for a total value of €41,084.05. Following the sale, the director owned 2,930 shares in the company, valued at approximately €58,863.70. This trade represents a 41.11% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Luciano Santel sold 2,023 shares of the business’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of €20.09, for a total value of €40,642.07. Following the transaction, the director owned 4,739 shares of the company’s stock, valued at €95,206.51. This trade represents a 29.92% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders have sold 14,249 shares of company stock valued at $268,346. Corporate insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Stevanato Group

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. State of Wyoming lifted its stake in shares of Stevanato Group by 39,216.7% in the 2nd quarter. State of Wyoming now owns 2,359 shares of the company’s stock worth $58,000 after acquiring an additional 2,353 shares during the period. GW&K Investment Management LLC increased its stake in shares of Stevanato Group by 76.2% during the fourth quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock valued at $49,000 after acquiring an additional 1,055 shares during the period. Quantbot Technologies LP bought a new stake in Stevanato Group during the third quarter worth approximately $68,000. Integrated Wealth Concepts LLC bought a new stake in Stevanato Group during the second quarter worth approximately $59,000. Finally, Fifth Third Bancorp lifted its position in Stevanato Group by 22.6% in the first quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock worth $58,000 after purchasing an additional 773 shares during the period.

Stevanato Group Trading Up 0.2%

NYSE STVN opened at €20.98 on Friday. Stevanato Group has a one year low of €12.89 and a one year high of €28.00. The company has a 50-day simple moving average of €20.55 and a 200-day simple moving average of €17.84. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.08 and a current ratio of 1.61. The firm has a market capitalization of $6.35 billion, a PE ratio of 37.47, a price-to-earnings-growth ratio of 1.71 and a beta of 0.75.

Stevanato Group (NYSE:STVN) last released its quarterly earnings data on Wednesday, August 5th. The company reported €0.14 earnings per share for the quarter, missing the consensus estimate of €0.15 by (€0.01). Stevanato Group had a return on equity of 10.43% and a net margin of 10.99%.The business had revenue of €302.00 million for the quarter. On average, equities analysts forecast that Stevanato Group will post 0.69 earnings per share for the current year.

Stevanato Group Company Profile

Stevanato Group S.p.A. is an Italy-based developer and manufacturer of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and healthcare industries. The company provides products and services designed to support the development, production and administration of injectable medicines.

Its portfolio includes glass vials, cartridges and syringes, as well as other primary packaging components and containment systems. Stevanato Group also offers inspection and packaging equipment, analytical and laboratory services, and drug-delivery technologies such as prefillable syringes and combination-device solutions.